| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 07/18/2007 | CN100998568A Benda-lysine oral disintegrant tablet and its preparing method |
| 07/18/2007 | CN100998565A Anti-angiogene compositions and methods of use |
| 07/18/2007 | CN100998407A Health-care food used for reliefing eyestrain, and its preparing method |
| 07/18/2007 | CA2554542A1 Use of acamprosate in the treatment of tinnitus |
| 07/17/2007 | US7244761 Nerve regeneration promoters containing semaphorin inhibitor as the active ingredient |
| 07/17/2007 | US7244753 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 07/17/2007 | US7244722 5-HT2A receptor related disorders; such as 1-(2-(2-fluoro-4-nitrophenoxy)ethyl)-3-(1piperazinyl)-2(1H)-pyrazinone |
| 07/17/2007 | US7244711 Mixtures of enzyme inhibitors and free radical scavengers selected from phenolic compounds, phenothiazines and diphenylamines, used for prophylaxis of rheumatic diseases, pancreatitis, multiple sclerosis or gastrointestinal disorders |
| 07/17/2007 | US7244412 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia |
| 07/17/2007 | CA2388639C Inhibitors of .alpha.l.beta.2 mediated cell adhesion |
| 07/17/2007 | CA2298445C Method and compositions for treating late phase allergic reactions and inflammatory diseases |
| 07/17/2007 | CA2160161C Use of derivatives of 2,4-bisubstituted phenols as 5-lipoxigenase inhibitors |
| 07/12/2007 | WO2007078326A1 Controlled pupil dilation for diagnostic and treatment of visual anomalies |
| 07/12/2007 | WO2007077783A1 Composition for soft contact lens and adsorption suppressing method |
| 07/12/2007 | WO2007045930A3 Modulation of trpv expression levels |
| 07/12/2007 | WO2007038549B1 Treatment of inflammation and vascular abnormalities of the eye |
| 07/12/2007 | WO2007029008A3 Method of treatment or prevention of age-related macular degeneration |
| 07/12/2007 | WO2007012974A3 Cyclodextrin nanotechnology for ophthalmic drug delivery |
| 07/12/2007 | WO2007005670A3 Natural and synthetic sulfoxide, selenone and selenoxide analogs and polymer conjugated forms thereof for the modulation of angiogenesis |
| 07/12/2007 | WO2006128152A3 Method to treat and prevent posterior capsule opacification |
| 07/12/2007 | WO2006107598A3 Conjugates of photoactive compound and a bulking group for enhancing photodynamic therapy |
| 07/12/2007 | WO2006050836A3 Ophthalmic emulsions containing prostaglandins |
| 07/12/2007 | US20070161647 QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 and NK-2 RECEPTOR ANTAGONISTS |
| 07/12/2007 | US20070161646 Piperidine Derivatives and Their Use as Modulators of Chemokine Receptor Activity (Especially CCR5) |
| 07/12/2007 | US20070161635 Kinase inhibitors |
| 07/12/2007 | US20070160603 Antibodies Against Tumor Necrosis Factor Delta (APRIL) |
| 07/11/2007 | EP1806135A2 The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation |
| 07/11/2007 | EP1804790A2 Use of inhibitors of jun n-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases |
| 07/11/2007 | EP1535065A4 Neuroprotective synergy of erythropoietin and insulin-like growth factor |
| 07/11/2007 | EP1458706B1 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 07/11/2007 | EP1204414B1 Use of morphinan derivates as medicines |
| 07/11/2007 | EP1028945B1 Substituted pyridine compounds as anti-inflammatory agents |
| 07/11/2007 | CN1997741A Novel mite allergen |
| 07/11/2007 | CN1997394A Compositions and methods comprising an EGFL7 antagonist for modulating vascular development |
| 07/11/2007 | CN1997381A Corneal neuritogenesis promoter containing PACAP and its derivative |
| 07/11/2007 | CN1994461A Lyophilization process of glutathione for injection |
| 07/11/2007 | CN1994317A Cerumen softening agent |
| 07/11/2007 | CN1325637C Ependymal neural stem cells and method for their isolation |
| 07/11/2007 | CN1325488C Heterocyclic derivatives |
| 07/11/2007 | CN1325479C Pyrimidine compounds |
| 07/11/2007 | CN1325086C Bear gall eyesight-improving tablet |
| 07/10/2007 | US7241789 Substituted indoles and their use as integrin antagonists |
| 07/10/2007 | US7241782 Modifications are prepared by subjecting an alkaline solution of torasemide to a rapid acidification with inorganic or organic acids at 0 to 35 degrees C. |
| 07/10/2007 | US7241778 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety |
| 07/10/2007 | US7241777 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors |
| 07/10/2007 | US7241766 Methods of using phenolic guanidine sodium channel blockers |
| 07/10/2007 | US7241738 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/10/2007 | US7241733 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| 07/10/2007 | US7241591 Adenovirus comprising a gene coding for glutathione peroxidase |
| 07/10/2007 | CA2421910C Xanthine phosphodiesterase v inhibitors |
| 07/10/2007 | CA2396814C Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical compositions containing them |
| 07/10/2007 | CA2380072C Nicotine in therapeutic angiogenesis and vasculogenesis |
| 07/10/2007 | CA2367092C Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
| 07/10/2007 | CA2184461C A method for inhibiting an irregular binding of human lens cells |
| 07/05/2007 | WO2007076467A2 Use of anecortave acetate as an adjunct during filtration bleb surgery |
| 07/05/2007 | WO2007076360A1 (indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)- pyrazines for treating rho kinase-mediated diseases and conditions |
| 07/05/2007 | WO2007074916A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 07/05/2007 | WO2007074753A1 Pharmaceutical comprising substituted urea derivative |
| 07/05/2007 | US20070155795 Muscarinic agonists |
| 07/05/2007 | US20070155788 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 07/05/2007 | US20070155775 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 07/05/2007 | US20070155756 Treatment of chemokine mediated diseases |
| 07/05/2007 | US20070155734 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 07/05/2007 | US20070155732 Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents |
| 07/05/2007 | US20070155713 Nitrogen-containing heterocyclic compounds and use thereof |
| 07/05/2007 | US20070154912 87 Human Secreted Proteins |
| 07/05/2007 | US20070154428 Thiazole derivative |
| 07/05/2007 | CA2821393A1 Rnai-mediated inhibition of rho kinase for treatment of ocular hypertension/glaucoma |
| 07/05/2007 | CA2632595A1 Rnai-mediated inhibition of hif1a for treatment of ocular angiogenesis |
| 07/05/2007 | CA2632508A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 07/05/2007 | CA2631838A1 Use of anecortave acetate as an adjunct during filtration bleb surgery |
| 07/04/2007 | EP1804064A1 Diagnostics and therapeutics for macular degeneration |
| 07/04/2007 | EP1803810A1 Integrin antagonists |
| 07/04/2007 | EP1803730A1 Albumin fusion proteins |
| 07/04/2007 | EP1803468A1 Agents for treatment of glaucomatours retinopathy and optic neuropathy |
| 07/04/2007 | EP1803451A1 Pufa supplements |
| 07/04/2007 | EP1802612A1 Novel b1 bradykinin receptor antagonists |
| 07/04/2007 | EP1802373A2 Carboxy-amido-triazoles for the localized teatment of ocular diseases |
| 07/04/2007 | EP1802325A2 Crig polypeptide for prevention and treatment of complement-associated disorders |
| 07/04/2007 | EP1802291A2 Calixarene-based peptide conformation mimetics, methods of use, and methods of making |
| 07/04/2007 | EP1802199A2 Isolated lineage negative hematopoietic stem cells and methods of treatment therewith |
| 07/04/2007 | EP1478741A4 Combination of a growth factor and a protease enzyme |
| 07/04/2007 | EP1286690B1 Use of alpha-msh and epo for the manufacture of a medicament for preventing or treating ischemic conditions |
| 07/04/2007 | CN1993118A Aqueous eye drops with accelerated intraocular migration permeability |
| 07/04/2007 | CN1990490A Dorzolamide intermediate preparation method |
| 07/04/2007 | CN1990474A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 07/04/2007 | CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 07/04/2007 | CN1989969A Cyclic protein tyrosine kinase inhibitors |
| 07/04/2007 | CN1324025C Tropane derivatives as CCR5 modulators |
| 07/04/2007 | CN1324019C New azadicyclo salt kind compound and its use in treating protein aging disease |
| 07/04/2007 | CN1323719C Remedy for glaucoma comprising Rho kinase inhibitor and beta-blocker |
| 07/03/2007 | US7238834 Piperidine derivatives and process for their production |
| 07/03/2007 | US7238811 Chemical compounds |
| 07/03/2007 | US7238716 Alkanoic acid derivatives process for their production and use thereof |
| 07/03/2007 | US7238713 Muscarinic agonists |
| 07/03/2007 | US7238710 A piperidin-2-one, 1,3-oxazinan-2-one, or 1,3-thiazinan-2-one compound for treatment of glaucoma, mediating the bone modeling and remodeling processes of the osteoblasts and osteoclasts; 7-{(4S)-4-[(3R)-3-hydroxy-4-phenylbutyl]-2-oxo-1,3-oxazinan-3-yl}heptanoic acid; side effect reduction |
| 07/03/2007 | US7238709 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence |
| 07/03/2007 | US7238703 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists |
| 07/03/2007 | US7238695 Imidazolyl derivatives |
| 07/03/2007 | US7238687 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |